Sign up to save your podcasts
Or
Share A Practical Look at Cardiorenal Protection for CKD in T2D: Applying Recent Data
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Practical Look at Cardiorenal Protection for CKD in T2D: Applying Recent Data
CME credits: 0.50
Valid until: 18-10-2024
Claim your CME credit at https://reachmd.com/programs/cme/a-practical-look-at-cardiorenal-protection-for-ckd-in-t2d-applying-recent-data/14594/
Optimal treatment with guideline-directed therapies, including RAS inhibitors, SGLT2 inhibitors, and nonsteroidal MRAs, is paramount in preventing progressive renal dysfunction and cardiorenal events in patients with chronic kidney disease and type 2 diabetes. As the patient becomes more complex, a multidisciplinary approach is often necessary to improve their outcomes. Listen in as our panel of experts offers strategies to improve collaboration and patient care.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.50
Valid until: 18-10-2024
Claim your CME credit at https://reachmd.com/programs/cme/a-practical-look-at-cardiorenal-protection-for-ckd-in-t2d-applying-recent-data/14594/
Optimal treatment with guideline-directed therapies, including RAS inhibitors, SGLT2 inhibitors, and nonsteroidal MRAs, is paramount in preventing progressive renal dysfunction and cardiorenal events in patients with chronic kidney disease and type 2 diabetes. As the patient becomes more complex, a multidisciplinary approach is often necessary to improve their outcomes. Listen in as our panel of experts offers strategies to improve collaboration and patient care.
=